NASDAQ:AVIR   Atea Pharmaceuticals, Inc.
3
I think we can see AVIR run up to the 1.6 area while waiting for the (2) P2 data points to be released 1Q.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.